Trial Profile
AiDing Diuresis wIth Tolvaptan (ADD-IT)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary) ; Furosemide; Metolazone
- Indications Oedema
- Focus Therapeutic Use
- Acronyms ADD-IT
- 25 Mar 2019 Status changed from recruiting to completed.
- 03 Apr 2018 Planned End Date changed from 1 Mar 2018 to 30 Dec 2018.
- 03 Apr 2018 Planned primary completion date changed from 1 Mar 2018 to 30 Dec 2018.